Drugs / Yi-Qi-Qing-Jie herbal compound
Yi-Qi-Qing-Jie herbal compound
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03418779 | Jul 2019 → Sep 2024 overdue | IgA glomerulonephritis | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Active not recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yi-Qi-Qing-Jie herbal compound | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03418779 ↗ |
| Known as | Yi-Qi-Qing-Jie formula | “Yi-Qi-Qing-Jie formula (YQF; a compound recipe of Chinese medicinal herbs) has shown potential renal protection in our previous clinical studies.” PMID 31907076 ↗ Jan 2020 |
| Known as | YQF | “Yi-Qi-Qing-Jie formula (YQF; a compound recipe of Chinese medicinal herbs) has shown potential renal protection in our previous clinical studies.” PMID 31907076 ↗ Jan 2020 |
| Modality | Traditional medicine (herbal / TCM) | “a compound recipe of Chinese medicinal herbs” PMID 31907076 ↗ Jan 2020 |
| Route | Oral | “taken orally twice a day” NCT03418779 ↗ |